BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

0.5101

24-January-25 15:45:00

15 minutes delayed

Stocks

-0.0114

-2.19%

Today's range

0.5010 - 0.5460

ISIN

N/A

Source

NASDAQ

Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration

02 Jun 2021 07:00:02 By Nasdaq GlobeNewswire
Bolt Biotherapeutics Reports First Quarter 2021 Financial Results and Provides Business Highlights

13 May 2021 15:05:00 By Nasdaq GlobeNewswire
Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001

10 Apr 2021 07:30:00 By Nasdaq GlobeNewswire
Bolt Biotherapeutics to Present at 20th Annual Needham Virtual Healthcare Conference

08 Apr 2021 06:00:00 By Nasdaq GlobeNewswire
Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights

31 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
Bolt Biotherapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

09 Feb 2021 15:05:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.